Artelo Biosciences Adopts Solana Treasury Strategy: A Game-Changer in Pharma and Crypto
Discover how Artelo Biosciences raised $9.475M to launch a Solana treasury strategy, becoming the first publicly traded pharma firm to adopt $SOL as a reserve asset.